Actualización en el manejo adecuado de la coxartosis de cadera

Abstract

ntroduction: Coxarthrosis is one of the most disabling pathologies in adults after 30 years of age and its incidence increases with age, it is considered one of the main health problems in the world, affecting 303 million people around the world. world. Development: Coxarthrosis is a chronic degenerative disease that affects articular cartilage and subchondral bone, the development of this involvement is influenced by the presence of risk factors such as age, sex, overweight, obesity, sedentary lifestyle. To make the diagnosis it is important to take into account the risk factors of each person and the clinic, it can also be helped by the use of imaging and laboratory tests. Once the diagnosis is made, the treatment of coxarthrosis in early stages is based on treating the symptoms with various types of analgesic drugs, which must be individualized for each patient according to their comorbidities. Currently there are therapies such as the use of Hilano GF20, platelet growth concentrate that have encouraging results. Conclusion: The coxarthrosis of the hip, being a chronic degenerative disease, its treatment is based on treating the symptoms with analgesics, whether oral or topical, currently there are therapies with encouraging results that currently regenerate the articular cartilage and bone, however, the study population is very small.